Skip to main content
Premium Trial:

Request an Annual Quote

NuSep Extends Closing Date on Share Purchase Offer

NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.

It added that to date, it has received about A$1.3 million ($1.4 million) of a targeted amount of A$2.1 million. The offering, which was announced in July and which had an original closing date of July 29, had been extended previously to Aug. 15.

The company is offering 21 million shares of iys stock at A$.10 per share, and in a prospectus said that if A$1.5 million is raised from the offering, A$200,000 would go toward the marketing of gels and IQ software, and A$1.3 million will be invested into a plasma project involving SingPharm in Singapore, which is using NuSep technology to manufacture therapeutic plasma products, and for general corporate purposes.

If A$2.1 million is raised, A$500,000 will be used for marketing of gel products and IQ software with the rest going toward the Singapore plasma project and general corporate purposes.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.